| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ANA.20425 |
| P698 | PubMed publication ID | 15786453 |
| P50 | author | David S Knopman | Q63967707 |
| Joseph E Parisi | Q67209577 | ||
| Bradley F Boeve | Q67501037 | ||
| Keith A Josephs | Q90859127 | ||
| Robert J Ivnik | Q114336656 | ||
| Dennis W. Dickson | Q30504740 | ||
| Glenn E. Smith | Q46205917 | ||
| Ronald C. Petersen | Q56839853 | ||
| P2860 | cites work | Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria | Q29614410 |
| The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease | Q29614948 | ||
| Differentiation of vascular dementia from AD on neuropsychological tests | Q33733780 | ||
| The prevalence of frontotemporal dementia | Q33959615 | ||
| The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia | Q34087665 | ||
| Patterns of brain atrophy in frontotemporal dementia and semantic dementia | Q34110685 | ||
| Survival in frontotemporal dementia | Q34221554 | ||
| PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA. | Q34256347 | ||
| Update on the neuropathological diagnosis of frontotemporal dementias | Q34475412 | ||
| Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). | Q36727765 | ||
| Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia | Q44322053 | ||
| Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. | Q46043966 | ||
| Frontotemporal dementia versus Alzheimer's disease: differential cognitive features | Q46261357 | ||
| Pathologic heterogeneity in clinically diagnosed corticobasal degeneration | Q48111354 | ||
| Neuropathology of cognitively normal elderly | Q48125911 | ||
| Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX. | Q48185158 | ||
| Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series | Q48212849 | ||
| Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. | Q48447237 | ||
| Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics | Q48661008 | ||
| A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations | Q48745677 | ||
| REM sleep behavior disorder and dementia: cognitive differences when compared with AD. | Q48768641 | ||
| Frontal lobe dementia with novel tauopathy: sporadic multiple system tauopathy with dementia. | Q48914222 | ||
| Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD. | Q52011967 | ||
| Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). | Q52888984 | ||
| SPECT in Dementia: Clinical and Pathological Correlation | Q53200614 | ||
| Dementia as the most common presentation of cortical-basal ganglionic degeneration. | Q53231913 | ||
| Pick's disease versus Alzheimer's disease: a comparison of clinical characteristics. | Q53318881 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 480-488 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Annals of Neurology | Q564414 |
| P1476 | title | Antemortem diagnosis of frontotemporal lobar degeneration | |
| P478 | volume | 57 |
| Q24186399 | 18 F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI) |
| Q36960858 | A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series |
| Q37648226 | A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology. |
| Q28756699 | Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease |
| Q34555422 | An algorithm for genetic testing of frontotemporal lobar degeneration |
| Q39135327 | Approach to atypical Alzheimer's disease and case studies of the major subtypes. |
| Q36455435 | Are clinical diagnoses of Alzheimer's disease and other dementias affected by education and self-reported race? |
| Q51886987 | Are subjective cognitive complaints a risk factor for dementia? |
| Q24650928 | Argyrophilic grains: a distinct disease or an additive pathology? |
| Q37874158 | Behavioural variant frontotemporal dementia--defining genetic and pathological subtypes |
| Q53464192 | Behavioural variant frontotemporal dementia: not all it seems? |
| Q38314824 | Biomarkers in the primary progressive aphasias |
| Q37253492 | CSF biomarkers in frontotemporal lobar degeneration with known pathology |
| Q64275200 | CSF placental growth factor - a novel candidate biomarker of frontotemporal dementia |
| Q53454566 | Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment. |
| Q36157458 | Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors |
| Q90118766 | Cerebrospinal fluid biomarkers and cognitive status in differential diagnosis of frontotemporal dementia and Alzheimer's disease |
| Q36626657 | Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease |
| Q89667348 | Classification of primary progressive aphasia: challenges and complexities |
| Q36533936 | Clinicopathologic correlation in PGRN mutations |
| Q36659716 | Clinicopathologic differences among patients with behavioral variant frontotemporal dementia |
| Q34712689 | Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia |
| Q46024825 | Combined magnetic resonance imaging and positron emission tomography brain imaging in behavioural variant frontotemporal degeneration: refining the clinical phenotype. |
| Q50899589 | Comparison of 2 diagnostic criteria for the behavioral variant of frontotemporal dementia. |
| Q58280051 | Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia |
| Q37800835 | Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review |
| Q51866617 | Dementia: what is behavioral variant frontotemporal dementia? |
| Q37531130 | Development and validation of pedigree classification criteria for frontotemporal lobar degeneration |
| Q47990209 | Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes |
| Q38372120 | Differentiating between subtypes of primary progressive aphasia and mild cognitive impairment on a modified version of the Frontal Behavioral Inventory |
| Q51889777 | Differentiating the frontal variant of Alzheimer's disease. |
| Q37024895 | Diffusion tensor tractography versus volumetric imaging in the diagnosis of behavioral variant frontotemporal dementia |
| Q36724611 | Disruption of large-scale neural networks in non-fluent/agrammatic variant primary progressive aphasia associated with frontotemporal degeneration pathology |
| Q51842124 | Does executive impairment define a frontal variant of Alzheimer's disease? |
| Q38035398 | EFNS task force: the use of neuroimaging in the diagnosis of dementia. |
| Q49914477 | Early vs late age at onset frontotemporal dementia and frontotemporal lobar degeneration |
| Q38939262 | Estimating the number of persons with frontotemporal lobar degeneration in the US population |
| Q35115185 | Extrapyramidal signs in the primary progressive aphasias |
| Q48091783 | Extrapyramidal signs, primitive reflexes and incontinence in fronto-temporal dementia |
| Q35977445 | Feasibility Study: Comparison of Frontal Cortex Needle Core Versus Open Biopsy for Detection of Characteristic Proteinopathies of Neurodegenerative Diseases |
| Q34088606 | Free and Cued Selective Reminding Identifies Very Mild Dementia in Primary Care |
| Q56388058 | Frontotemporal dementia |
| Q37069848 | Frontotemporal dementia: clinicopathological correlations |
| Q57741561 | Global Functional Coupling of Resting EEG Rhythms is Abnormal in Mild Cognitive Impairment and Alzheimer’s Disease |
| Q37179006 | Impaired action knowledge in amyotrophic lateral sclerosis |
| Q36861179 | Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI. |
| Q42542896 | Longitudinal decline in autopsy-defined frontotemporal lobar degeneration |
| Q42792695 | Morphological Factor Estimation via High-Dimensional Reduction: Prediction of MCI Conversion to Probable AD. |
| Q37980047 | Neuroimaging in frontotemporal lobar degeneration--predicting molecular pathology |
| Q38084188 | Neuroimaging of rapidly progressive dementias, part 1: neurodegenerative etiologies |
| Q37879961 | Neuropathological background of phenotypical variability in frontotemporal dementia |
| Q41253355 | Neurophysiological assessment of Alzheimer's disease individuals by a single electroencephalographic marker |
| Q34053430 | Neuropsychological patterns in magnetic resonance imaging-defined subgroups of patients with degenerative dementia |
| Q37390851 | Neuropsychological strategies for detecting early dementia |
| Q41820674 | Patient care and management of frontotemporal lobar degeneration |
| Q36720041 | Patterns of brain atrophy in clinical variants of frontotemporal lobar degeneration |
| Q58277419 | Patterns of decline in naming and semantic knowledge in primary progressive aphasia |
| Q38101085 | Phenotypic variety in the presentation of frontotemporal lobar degeneration |
| Q44901778 | Prevalence and topography of small hypointense foci suggesting microbleeds on 3T susceptibility-weighted imaging in various types of dementia |
| Q37688883 | Primary progressive aphasia: clinicopathological correlations |
| Q46467732 | Principal component analysis of FDG PET in amnestic MCI. |
| Q37358565 | Progressive aphasia secondary to Alzheimer disease vs FTLD pathology |
| Q38408108 | Quantitative and qualitative analyses of clock drawing in frontotemporal dementia and Alzheimer's disease |
| Q33830518 | Recent insights into the molecular genetics of dementia |
| Q48661492 | Resting state cortical electroencephalographic rhythms are related to gray matter volume in subjects with mild cognitive impairment and Alzheimer's disease |
| Q24598142 | Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia |
| Q39802035 | Stability of clinical condition in mild cognitive impairment is related to cortical sources of alpha rhythms: an electroencephalographic study |
| Q36952445 | TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease |
| Q48031199 | The Pitfall of Behavioral Variant Frontotemporal Dementia Mimics Despite Multidisciplinary Application of the FTDC Criteria |
| Q38866379 | The Prevalence and Incidence of Frontotemporal Dementia: a Systematic Review |
| Q53077511 | The added value of 18-fluorodeoxyglucose-positron emission tomography in the diagnosis of the behavioral variant of frontotemporal dementia. |
| Q35992776 | The non-fluent/agrammatic variant of primary progressive aphasia |
| Q34380374 | Time-to-event voxel-based techniques to assess regional atrophy associated with MCI risk of progression to AD. |
| Q57314841 | Usefulness of EEG Techniques in Distinguishing Frontotemporal Dementia from Alzheimer's Disease and Other Dementias |
Search more.